Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystectomy | 4 | 2019 | 631 | 0.830 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2020 | 476 | 0.540 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2021 | 2076 | 0.540 |
Why?
|
| Testicular Neoplasms | 1 | 2020 | 767 | 0.500 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1157 | 0.430 |
Why?
|
| Kidney Neoplasms | 3 | 2023 | 4015 | 0.430 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2023 | 2952 | 0.410 |
Why?
|
| Lung Diseases | 1 | 2021 | 1904 | 0.390 |
Why?
|
| Reoperation | 1 | 2019 | 4177 | 0.370 |
Why?
|
| Prostatectomy | 4 | 2021 | 1795 | 0.240 |
Why?
|
| Convalescence | 1 | 2020 | 107 | 0.200 |
Why?
|
| Hormone Antagonists | 1 | 2020 | 111 | 0.190 |
Why?
|
| Nephrectomy | 2 | 2022 | 1004 | 0.170 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 1582 | 0.160 |
Why?
|
| Myocarditis | 1 | 2022 | 697 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2021 | 7901 | 0.130 |
Why?
|
| Colectomy | 1 | 2020 | 650 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 1187 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2020 | 902 | 0.120 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2020 | 1191 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2022 | 72439 | 0.110 |
Why?
|
| Incidence | 6 | 2021 | 20761 | 0.110 |
Why?
|
| Prostatic Neoplasms | 4 | 2021 | 10598 | 0.110 |
Why?
|
| Intestines | 1 | 2021 | 1918 | 0.110 |
Why?
|
| Postoperative Complications | 3 | 2020 | 15101 | 0.100 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 628 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 2 | 2012 | 2276 | 0.100 |
Why?
|
| Receptors, Androgen | 2 | 2013 | 1049 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2019 | 2326 | 0.090 |
Why?
|
| Monoamine Oxidase | 1 | 2008 | 170 | 0.080 |
Why?
|
| Risk Factors | 6 | 2020 | 70927 | 0.080 |
Why?
|
| Prognosis | 5 | 2022 | 28987 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 1498 | 0.080 |
Why?
|
| Humans | 19 | 2023 | 715636 | 0.070 |
Why?
|
| Androgens | 1 | 2013 | 1232 | 0.070 |
Why?
|
| Male | 13 | 2021 | 350156 | 0.070 |
Why?
|
| Aged | 9 | 2021 | 162383 | 0.070 |
Why?
|
| Prostate | 1 | 2012 | 1593 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3407 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2019 | 4375 | 0.060 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2017 | 2115 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2718 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2020 | 23482 | 0.060 |
Why?
|
| Neoplasms | 2 | 2022 | 20514 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2014 | 1980 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15899 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 40892 | 0.050 |
Why?
|
| Adolescent | 4 | 2020 | 85064 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 56137 | 0.050 |
Why?
|
| Absenteeism | 1 | 2020 | 274 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 214618 | 0.040 |
Why?
|
| Female | 8 | 2020 | 377052 | 0.040 |
Why?
|
| United States | 3 | 2020 | 67894 | 0.040 |
Why?
|
| Adult | 6 | 2020 | 212228 | 0.040 |
Why?
|
| SEER Program | 1 | 2021 | 1569 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1844 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 14438 | 0.030 |
Why?
|
| Direct Service Costs | 1 | 2014 | 64 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2012 | 8892 | 0.030 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2014 | 59 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 11665 | 0.030 |
Why?
|
| Free Tissue Flaps | 1 | 2017 | 286 | 0.030 |
Why?
|
| Vimentin | 1 | 2013 | 273 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 453 | 0.030 |
Why?
|
| Microsurgery | 1 | 2017 | 811 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11138 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6320 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1686 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1627 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1670 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 912 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 712 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2014 | 978 | 0.020 |
Why?
|
| Propensity Score | 1 | 2014 | 1759 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3631 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11665 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2013 | 8561 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58288 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18774 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 1673 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2493 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7445 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8238 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6272 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9812 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39334 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10603 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13219 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12490 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 13210 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12495 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 13606 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 15184 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 80320 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 40042 | 0.000 |
Why?
|
| Animals | 1 | 2013 | 169277 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_